Department of Medicine, University of California, San Francisco, California 94143, USA.
J Nephrol. 2012 May-Jun;25(3):317-24. doi: 10.5301/JN.2011.8454.
Excess weight is paradoxically associated with better cardiovascular disease (CVD) outcomes and mortality in end-stage renal disease (ESRD) patients treated with hemodialysis. This association has been observed in chronic kidney disease (CKD) as well. One potential explanation for this inverse relationship is that the usual positive correlation between severity of CVD risk factors and higher body mass index (BMI) is reversed in CKD. To test this hypothesis, we determined the relationship between BMI and CVD risk factors in patients with and without CKD.
This was a cross-sectional study of the nationally representative US National Health and Nutrition Examination Survey (NHANES) 1999-2006. CKD was defined as glomerular filtration rate <60 ml/min per 1.73 m2. Covariates were age, race/ethnicity, sex and use of relevant prescription medications. Outcome variables were total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, systolic blood pressure (SBP), diastolic blood pressure (DBP), C-reactive protein (CRP) and fasting glucose (FG).
There were 1,895 and 32,431 patients with and without CKD, respectively. Those with CKD were older and had higher BMI. The shapes of the association between BMI and total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, SBP, CRP and FG were similar in those with or without CKD. In a sensitivity analysis excluding patients taking relevant prescription medications, our results did not differ substantially.
CKD did not alter the shapes of the association between higher BMI and CVD risk factors. Inverse associations between BMI and CVD risk factors are unlikely to explain why CKD patients with higher BMI may have better outcomes.
在接受血液透析治疗的终末期肾病(ESRD)患者中,超重与更好的心血管疾病(CVD)结局和死亡率呈反常相关。这种相关性在慢性肾脏病(CKD)中也有观察到。这种反向关系的一个潜在解释是,在 CKD 中,CVD 风险因素的严重程度与更高的体重指数(BMI)之间的通常正相关被逆转。为了验证这一假设,我们确定了 CKD 患者和非 CKD 患者的 BMI 与 CVD 风险因素之间的关系。
这是一项对具有全国代表性的美国国家健康和营养调查(NHANES)1999-2006 年数据的横断面研究。CKD 的定义为肾小球滤过率<60 ml/min/1.73 m2。协变量为年龄、种族/族裔、性别和相关处方药的使用。结果变量为总胆固醇、LDL 胆固醇、HDL 胆固醇、甘油三酯、收缩压(SBP)、舒张压(DBP)、C 反应蛋白(CRP)和空腹血糖(FG)。
分别有 1895 例和 32431 例 CKD 患者和非 CKD 患者。CKD 患者年龄较大,BMI 较高。在 CKD 患者和非 CKD 患者中,BMI 与总胆固醇、LDL 胆固醇、HDL 胆固醇、甘油三酯、SBP、CRP 和 FG 之间的关联形状相似。在排除服用相关处方药的患者的敏感性分析中,我们的结果没有太大差异。
CKD 并未改变 BMI 与 CVD 风险因素之间的关联形状。BMI 与 CVD 风险因素之间的负相关不太可能解释为什么 BMI 较高的 CKD 患者可能有更好的结局。